Last reviewed · How we verify
GVAX Pancreas
GVAX Pancreas is a Biologic drug developed by Aduro Biotech, Inc.. It is currently in Phase 2 development. Also known as: GVAX.
At a glance
| Generic name | GVAX Pancreas |
|---|---|
| Also known as | GVAX |
| Sponsor | Aduro Biotech, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer (PHASE2)
- Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas (PHASE2)
- Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. (PHASE1, PHASE2)
- Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer (PHASE1, PHASE2)
- Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer (PHASE2)
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer (PHASE2)
- Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas (EARLY_PHASE1)
- Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GVAX Pancreas CI brief — competitive landscape report
- GVAX Pancreas updates RSS · CI watch RSS
- Aduro Biotech, Inc. portfolio CI
Frequently asked questions about GVAX Pancreas
What is GVAX Pancreas?
GVAX Pancreas is a Biologic drug developed by Aduro Biotech, Inc..
Who makes GVAX Pancreas?
GVAX Pancreas is developed by Aduro Biotech, Inc. (see full Aduro Biotech, Inc. pipeline at /company/aduro-biotech-inc).
Is GVAX Pancreas also known as anything else?
GVAX Pancreas is also known as GVAX.
What development phase is GVAX Pancreas in?
GVAX Pancreas is in Phase 2.
Related
- Manufacturer: Aduro Biotech, Inc. — full pipeline
- Also known as: GVAX
- Compare: GVAX Pancreas vs similar drugs
- Pricing: GVAX Pancreas cost, discount & access